NASDAQ | ETF
The fund normally invests at least 80% of assets in securities of disruptive medicine companies.
Fidelity's disruptive strategies seek to identify innovative developments that could signal new directions for delivering products and services to customers.
Generally, these companies have or are developing new or unconventional ways of doing business that could disrupt and displace incumbents over time.
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| EXAS | EXACT Sciences Corporation | Healthcare | Diagnostics & Research | 5.04% |
| UCB | UCB SA | Healthcare | Biotechnology | 4.23% |
| DHR | Danaher Corporation | Healthcare | Diagnostics & Research | 4.11% |
| BSX | Boston Scientific Corp | Healthcare | Medical Devices | 3.95% |
| ARGX | argenx NV ADR | Healthcare | Biotechnology | 3.82% |
| UMRX | Cogent Biosciences Inc | Healthcare | Biotechnology | 3.64% |
| ALNY | Alnylam Pharmaceuticals Inc | Healthcare | Biotechnology | 3.39% |
| ISRG | Intuitive Surgical Inc | Healthcare | Medical Instruments & Supplies | 3.37% |
| VEEV | Veeva Systems Inc Class A | Healthcare | Health Information Services | 3.20% |
| MRNA | Moderna Inc | Healthcare | Biotechnology | 2.75% |
| WAY | Waystar Holding Corp. Common Stock | Healthcare | Health Information Services | 2.59% |
| LFST | Lifestance Health Group Inc | Healthcare | Medical Care Facilities | 2.58% |
| EW | Edwards Lifesciences Corp | Healthcare | Medical Devices | 2.55% |
| PODD | Insulet Corporation | Healthcare | Medical Devices | 2.50% |
| MASI | Masimo Corporation | Healthcare | Medical Devices | 2.33% |
| PCVX | Vaxcyte Inc | Healthcare | Biotechnology | 2.20% |
| INSM | Insmed Inc | Healthcare | Biotechnology | 1.99% |
| RPRX | Royalty Pharma Plc | Healthcare | Biotechnology | 1.88% |
| LEGN | Legend Biotech Corp | Healthcare | Biotechnology | 1.86% |
| MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 1.83% |